Why mNGS Standards Matter for Microbiome Analysis

Reliable microbiome analysis standards are the foundation of reproducible metagenomic next-generation sequencing (mNGS) results, yet many laboratories still run complex microbiome workflows without systematic quality controls. A joint webinar between ATCC (American Type Culture Collection) and Micronbrane Medical examined how mock community standards, spike-in controls, and validated reference materials help identify bias at every step of the mNGS workflow, from DNA extraction through bioinformatic analysis.

Watch the full webinar:

Key Takeaways

Each step of the mNGS workflow, from extraction to bioinformatics, introduces measurable bias that reference standards can quantify
Whole-cell mock communities reveal extraction bias, while genomic DNA mixes isolate downstream library preparation and sequencing variability
Different extraction kits show dramatically different recovery profiles for gram-positive versus gram-negative organisms using the same standard input
ATCC’s spike-in control (MSA-1014) enables absolute quantification of microbiome content, moving beyond relative abundance reporting
Consistent use of standards ensures reproducibility across users, days, and sites in clinical and research settings

The Growth of Microbiome Research and Its Quality Problem

The microbiome field has expanded rapidly over the past two decades. PubMed publications containing “microbiome” have roughly doubled in the last four years alone, approaching 150,000 total. Google hits for the term have grown tenfold to over 110 million, reflecting public interest that extends well beyond the research community. Over 3,700 clinical trials are now registered under the keyword “microbiome,” with nearly 600 additional trials for fecal microbiota transplant (FMT).

This growth reached a milestone with FDA approval of the first two microbiome-related therapeutics: Rebyota (late 2022) and Vowst (early 2023), both for recurrent Clostridioides difficile infection.

However, rapid growth has outpaced standardization. As microbiome research moves toward clinical translation, including therapeutics, personalized medicine, and multi-site clinical trials, the lack of consistent quality controls undermines confidence in published results. Two laboratories analyzing the same sample with different protocols can arrive at different microbial profiles, not because the biology differs, but because unchecked bias accumulates at each workflow step.

Where Bias Enters the mNGS Workflow

ATCC’s systematic evaluation using defined mock communities demonstrates that bias is not hypothetical. It is measurable and, in some cases, severe.

Extraction Bias

Using the ATCC 6-member even mock community (MSA-1000), sequencing the genomic DNA mix produced coverage values nearly identical to expected proportions. But when the same community was provided as whole cells requiring lysis and extraction, dramatic discrepancies appeared. Extraction Kit A showed poor recovery of Staphylococcus species, while Kit B underperformed on Streptococcus. Neither kit produced uniform coverage across all six organisms. These extraction biases are compounded by reagent contamination that varies by brand and lot.

This result is well known among experienced microbiome researchers, but the specific magnitude of the bias can only be quantified with a defined standard. Without a mock community as a reference, there is no way to distinguish biological variation from technical artifact.

Library Preparation Bias

For 16S ribosomal RNA (rRNA) gene-based library construction, primer choice significantly affects coverage. Comparing V1-V3 and V1-V2 primer sets on the same standard input showed that V1-V3 was less efficient for certain taxa. This primer bias is a recognized limitation of amplicon-based approaches, but its magnitude varies with the specific organisms in the sample.

Even within whole-genome shotgun (WGS) library preparation, kit selection matters. Using the same ATCC 6-member standard (MSA-1000) on Illumina, the Nextera workflow produced less than 2% coverage for one community member (Acinetobacter), while the Nextera Flex workflow recovered all six members at near-equal proportions matching expected values. The only variable changed was the library preparation kit.

Sequencing Platform Variability

Comparing four Illumina platforms (MiSeq, MiniSeq, NextSeq, NovaSeq) using the ATCC 10-member even mix (MSA-3001) showed that coverage was comparable across all platforms and closely matched expected results. When the more challenging 20-member staggered mix (MSA-1003) was used, both 16S-based and shotgun approaches performed equally well across platforms. This finding indicates that once extraction and library preparation biases are controlled, the sequencing platform itself is a relatively minor source of variability.

Reference Standards for Microbiome Analysis: Whole Cells vs. Genomic DNA

ATCC provides mock community standards in two forms, and the choice depends on which portion of the workflow requires validation:

Whole-cell mock communities are appropriate for establishing a complete workflow from sample processing through sequencing. They reveal biases in lysis efficiency, nucleic acid recovery, and quantification, all of which occur before library preparation.
Genomic DNA mixes are appropriate for validating downstream steps, from library preparation through sequencing and bioinformatic analysis. Because the DNA is pre-extracted and quantified by digital PCR, any variability observed is attributable to the downstream workflow.

Available formats range from 6-member even communities for basic workflow validation to 20-member staggered communities that simulate the unequal abundance distributions found in real biological samples. Specialized standards include an 11-member bloodborne pathogen mix developed with LGC for clinical NGS-based pathogen detection, and environmental controls developed with the ABRF Metagenomic Research Group (ABRF-MGRG) containing relevant environmental microbes.

The standards also serve as ongoing quality controls, not just for initial workflow establishment. Consistent day-to-day, user-to-user, and site-to-site performance monitoring requires running the same defined standard through the complete workflow at regular intervals.

Moving from Relative to Absolute Quantification with Spike-In Controls

Most microbiome results are reported as relative abundance, which masks real changes in microbial load. If one taxon increases in absolute abundance while others remain constant, relative abundance analysis will show the unchanged taxa as having decreased. This makes it difficult to identify which organisms are actually changing in therapeutic studies or longitudinal monitoring.

ATCC developed a spike-in control (MSA-1014) consisting of three organisms, Escherichia coli, Clostridium sporogenes, and Staphylococcus aureus, each carrying a single-copy synthetic V1-V4 16S rRNA tag of approximately 800 base pairs with near-identical GC content. By adding a known quantity of this spike-in to an unknown sample, the sequencing output from the spike-in provides a calibration reference that enables back-calculation of absolute microbial quantities in the sample.

Validation experiments confirmed that the spike-in mix does not interfere with sequencing results of the sample community. Coverage of a 10-member mock community was identical whether spiked or unspiked, at both 1:10 and 1:100 ratios. Quantification accuracy using the spike-in was within a quarter-log of digital PCR measurements for most organisms, with WGS normalization showing slight bias toward low-GC organisms and 16S V1-V4 normalization producing tighter overall results.

Applying Standards Across the mNGS Workflow

For laboratories building or validating mNGS workflows, the systematic approach recommended is to work backward: validate sequencing first, then library preparation, then extraction. Each step should be validated independently using the appropriate standard format before combining into an end-to-end workflow assessment.

Micronbrane Medical’s mNGS product line, including the Devin Host Depletion Filter, Devin Microbial DNA Enrichment Kit, and mNGS-grade library preparation reagents, is designed to minimize the reagent contamination and extraction biases that standards help identify. As Dr. Mengchu Wu noted during the webinar discussion, clinical samples contain not only intact microbial cells but also cell-free DNA (cfDNA) in both fragmented and high-molecular-weight forms. A complete workflow validation must account for both particle-associated and cell-free microbial nucleic acids, which is why testing with both whole-cell and DNA standards is essential.

About the Speaker

Leka Papazisi, PhD – Principal Scientist, ATCC Mengchu Wu, PhD – Co-founder, CEO, and Chairwoman, Micronbrane Medical